News

BBG Advanced Therapies collects first cell donation on one-of-a-kind bus

In this edition of Blueprint for breakthroughs Adrienne compares Country Music and Cell and Gene Therapies

If You’re Gonna Play in Cell Therapy, You’ve Got to….

November 4, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Chris White and Emmanuel Casasola Master Control Keynote

Every Second Counts: BioBridge Global at the Master Control 2025 Summit

October 27, 2025

Master Control 2025 Summit Keynote – Prepared for web publication Opening Please welcome Emmanuel Casa Sola of BioBridge Global. Every second counts. In the time

in this edition of Blueprint for breakthroughs read how Adrienne Mendoza discusses scaling hope in access for patients with the Mobile Leukapheresis Center

Scaling Access: How Mobile Leukapheresis and Collaboration Are Powering the Next Era of Cell and Gene Therapy

October 23, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

BBG Advanced Therapies collected its first cell donation from Simon Hart in its Mobile Leukapheresis Center.

BBG Advanced Therapies collects first cell donation on one-of-a-kind bus

October 22, 2025

New vehicle to help enable lifesaving new advanced therapies The world’s only mobile leukapheresis center recorded its first cell donation on Monday, Oct. 20, marking

Adrienne Mendoza Blueprint for breakthroughs and Resilience in the Cell and Gene Therapy industry

Progress When Systems Stand Still: Resilience and Access in Cell and Gene Therapy

October 7, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

BBG Advanced Therapies and CELLforCURE Partner to Provide Transatlantic Manufacturing Solutions for Advanced Therapy Medicinal Products (ATMPs)

October 7, 2025

Collaboration establishes a transatlantic connection enabling U.S. companies to leverage CELLforCURE’s manufacturing capabilities in Europe, while European companies can benefit from BBG Advanced Therapies’ production

Adrienne B. Mendoza, Allogeneic Cell Therapies

The Donor Advantage: Why U.S. Starting Materials Are the Launchpad for Global Cell Therapy

September 23, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

What Europe taught Adrienne Mendoza about CGT access

Building Bridges: What Europe Just Taught Me About Scaling CGT Access

September 12, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Adrienne Mendoza Blueprint for breakthroughs: FDA's New Rare Disease Pathway and the future of CGT

Access in Advanced Therapies: How Regulatory Agility and Delivery Innovation Can Transform Patient Outcomes

September 9, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Blueprint For Breakthroughs: Adrienne Mendoza Rethinks How Advanced Therapies Can Be Scaled.

CGT Wake Up Call To Rethink How Advanced Therapies Scale

August 26, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

The blood bank and the future of cell & gene therapies. Blueprint for Breakthroughs.

The Blood Bank and the Future of Advanced Therapies

August 12, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Adrienne B Mendoza, Blueprint for breakthroughs, Potency Testing for advanced therapies

How Potency Testing Can Delay Advanced Therapies

August 12, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally